Trading Signals: EDIT Stock Price Prediction and Forecast (Wed. Feb. 3, 2016 - Fri. Dec. 22, 2023)(EDITAS MEDICIN)
| EDIT latest price $37.2500 (2.87%) ($35.8700 - $37.2800) on Thu. Jun. 14, 2018. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.4% (three month average) | RSI | 54 | Latest Price | $37.2500(2.87%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | EDIT declines -0.3% a day on average for past five trading days. | Weekly Trend | EDIT declines -0.2% a week on average for past two weeks. | Market Behavior | Growth stock rally for large cap. Growth stock rally for small cap. | Correlated ETFs | Broad market will support EDIT advance at 0% a week (0% probability) IBB(64%) ARKG(62%) XBI(61%) IWO(59%) ARKK(57%) | Factors Impacting EDIT price | EDIT will decline at least -1.7% in a week (0% probabilities). VXX(-13%) VIXM(-12%) TLT(-5%) GDXJ(-5%) SHY(-4%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.7% (StdDev 3.4%) | Hourly BBV | 0 () | Intraday Trend | 2.8% | | | |
|
5 Day Moving Average | $36.97(0.76%) | 10 Day Moving Average | $37.26(-0.03%) | 20 Day Moving Average | $36.75(1.36%) | To recent high | -10.3% | To recent low | 18.6% | Market Cap | $2.313b | | | | Editas Medicine, Inc. engages in the development and commercialization of genome editing technology. Its technology includes clustered, regularly interspaced short palindromic repeats (CRISPR), and CRISPR associated protein 9 (Cas9). The company was founded by Feng Zhang, Jennifer A. Doudna, George McDonald Church, J. Keith Joung and David R. Liu in September 2013 and is headquartered in Cambridge, MA. |